Inventor · disambiguated record
Marion Wiesmann
Also filed as: WIESMANN MARION
9 granted patents·5 pending applications·209 citations·filing 2003–2021
90Inventor score
Top patents by PatentIndex Score
14 records- 0194US8217035B2Pyrimidine derivatives used as PI-3-kinase inhibitorsBURGER MATTHEW·Filed 2007·Granted Jul 10, 2012·61 cites·7 claims
- 0292US8563549B2Pyrimidine derivatives used as PI-3 kinase inhibitorsBURGER MATTHEW·Filed 2012·Granted Oct 22, 2013·43 cites·16 claims
- 0390US7553854B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Granted Jun 30, 2009·20 cites·78 claims
- 0489US8173689B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingSUTTON JAMES C·Filed 2009·Granted May 8, 2012·14 cites·6 claims
- 0589US7470709B2Benzimidazole quinolinones and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Dec 30, 2008·36 cites·17 claims
- 0686US8710048B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingSUTTON JAMES C·Filed 2012·Granted Apr 29, 2014·12 cites·28 claims
- 0783US7825132B2Inhibition of FGFR3 and treatment of multiple myelomaNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Nov 2, 2010·19 cites·9 claims
- 0869US8293769B2CSF-1R inhibitors, compositions, and methods of useNG SIMON C·Filed 2008·Granted Oct 23, 2012·2 cites·39 claims
- 0965US8299081B2Methods for treating drug resistant cancerMICHELSON GLENN C·Filed 2006·Granted Oct 30, 2012·2 cites·20 claims
- 1059US2009281100A1Benzimidazole quinolinones and uses thereofBARSANTI PAUL A·Filed 2008·Application pending·0 cites
- 1154US2005203101A1Benzimidazole quinolinones and uses thereofCHIRON CORP·Filed 2004·Application pending·0 cites
- 1244US2010086518A1Treatment of melanomaNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1343US2010075965A1Pi3 kinase inhibitors and methods of their useNOVARTIS AG·Filed 2007·Application pending·0 cites
- 1443US2023172920A1Dosing regimen for treating a disease modulated by csf-1rNOVARTIS AG·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marion Wiesmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →